Physician
Children's Physicians
Children's Physicians was paid $39.42M by Medicaid between Jan 2018 and Dec 2024, across 112 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.
33Billing provider infoCHILDREN'S PHYSICIANS
OMAHA, NE 68114
OMAHA, NE 68114
33aNPI1750443503assigned 12/15/2006
33bProvider typePediatrics Physician
28Total paid$39.42M
24GClaims813,222
24DCodes billed112
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Nebraska
Rank by total paid#1 of 29
Median peer was paid$183K
This provider vs. median215×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 108,087 | $5.03M | |
| 2019 | 102,101 | $4.88M | |
| 2020 | 89,257 | $3.93M | |
| 2021 | 120,734 | $5.46M | |
| 2022 | 131,600 | $6.75M | |
| 2023 | 154,303 | $7.97M | |
| 2024incomplete | 107,140 | $5.40M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 39% | 265,812 | 249,534 | $15.38M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 13% | 55,841 | 55,035 | $5.24M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 11% | 47,805 | 44,464 | $4.18M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.0% | 36,637 | 34,667 | $3.14M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.9% | 28,969 | 28,623 | $2.74M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.4% | 12,667 | 12,553 | $1.32M |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.5% | 7,146 | 6,969 | $987K |
| 90686 | 2.2% | 60,816 | 60,281 | $859K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.7% | 18,344 | 17,739 | $688K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.3% | 23,024 | 22,723 | $532K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.3% | 11,306 | 11,056 | $524K |
| 90670 | 1.1% | 26,841 | 26,507 | $415K |
100 more codes
| 90648 | 1.0% | 27,938 | $406K | |
| 90723 | <1% | 19,411 | $285K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 6,364 | $236K |
| 96127 | <1% | 3,919 | $197K | |
| 90680 | <1% | 13,073 | $194K | |
| 90677 | <1% | 4,535 | $182K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,319 | $176K |
| 90633 | <1% | 10,633 | $151K | |
| 0071A | <1% | 2,645 | $100K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,037 | $99K |
| 99460 | <1% | 892 | $93K | |
| 0072A | <1% | 2,309 | $88K | |
| 90651 | <1% | 4,225 | $74K | |
| 92551 | <1% | 4,792 | $72K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 854 | $61K |
| 80061 | Lipid panel | <1% | 3,792 | $54K |
| 90656 | <1% | 4,822 | $47K | |
| 90734 | <1% | 2,534 | $44K | |
| 0111A | <1% | 1,158 | $43K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 849 | $43K |
| 0002A | <1% | 1,108 | $42K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,909 | $39K |
| 0124A | <1% | 966 | $36K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 454 | $36K |
| 85018 | <1% | 14,052 | $36K | |
| 0001A | <1% | 917 | $35K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,061 | $31K |
| 0154A | <1% | 802 | $30K | |
| 90710 | <1% | 1,743 | $29K | |
| 0112A | <1% | 764 | $29K | |
| 90696 | <1% | 1,597 | $25K | |
| 90681 | <1% | 1,711 | $24K | |
| 0074A | <1% | 610 | $23K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,296 | $23K |
| 90672 | <1% | 1,235 | $22K | |
| 0054A | <1% | 583 | $22K | |
| 99188 | <1% | 1,058 | $20K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 152 | $19K |
| Q3014 | Telehealth originating site facility fee | <1% | 959 | $19K |
| 90715 | <1% | 950 | $15K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 270 | $14K |
| 91321 | <1% | 697 | $14K | |
| 92583 | <1% | 437 | $13K | |
| 94010 | <1% | 291 | $12K | |
| 99173 | <1% | 5,346 | $11K | |
| 90700 | <1% | 720 | $10K | |
| 90716 | <1% | 617 | $10K | |
| 90707 | <1% | 608 | $10K | |
| 92552 | <1% | 709 | $10K | |
| 90461 | <1% | 4,608 | $10K | |
| 0164A | <1% | 279 | $10K | |
| 0004A | <1% | 248 | $9K | |
| 90620 | <1% | 245 | $7K | |
| 0052A | <1% | 179 | $7K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 141 | $6K |
| 87081 | <1% | 798 | $6K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 42 | $5K |
| 0051A | <1% | 137 | $5K | |
| 91322 | <1% | 225 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 225 | $4K |
| 99177 | <1% | 539 | $4K | |
| 99383 | <1% | 32 | $4K | |
| 99000 | <1% | 9,030 | $3K | |
| 90480 | <1% | 178 | $3K | |
| 90685 | <1% | 239 | $3K | |
| 83655 | <1% | 152 | $2K | |
| 0142A | <1% | 80 | $2K | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 1,041 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,210 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 121 | $1K |
| 0141A | <1% | 49 | $1K | |
| 36416 | <1% | 24,148 | $1K | |
| 0144A | <1% | 41 | $1K | |
| 81002 | <1% | 368 | $1K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 93 | $990.15 |
| 94375 | <1% | 12 | $791.68 | |
| 90660 | <1% | 79 | $708.56 | |
| 54150 | <1% | 12 | $690.89 | |
| 99462 | <1% | 14 | $660.59 | |
| 94664 | <1% | 25 | $578.44 | |
| 99429 | <1% | 20 | $481.47 | |
| 90688 | <1% | 856 | $473.38 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 77 | $430.50 |
| 90381 | <1% | 35 | $384.89 | |
| 69209 | <1% | 28 | $342.36 | |
| 81025 | <1% | 32 | $256.67 | |
| 88720 | <1% | 40 | $203.84 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 14 | $183.89 |
| 86580 | <1% | 12 | $92.78 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 14 | $88.55 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 16 | $2.83 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 41 | $0.50 |
| 91315 | 0% | 319 | $0.00 | |
| 91316 | 0% | 107 | $0.00 | |
| 91307 | 0% | 2,140 | $0.00 | |
| 91305 | 0% | 342 | $0.00 | |
| 94760 | 0% | 15 | $0.00 | |
| 91300 | 0% | 468 | $0.00 | |
| 91312 | 0% | 366 | $0.00 | |
| 91311 | 0% | 759 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTEVENSON, SHIELA (ADMINISTRATIVE ASSISTANT)